| Product NDC: | 51292-111 |
| Proprietary Name: | IPRIVASK |
| Non Proprietary Name: | DESIRUDIN |
| Active Ingredient(s): | & nbsp; DESIRUDIN |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 51292-111 |
| Labeler Name: | CANYON PHARMACEUTICALS, INC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021271 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100830 |
| Package NDC: | 51292-111-12 |
| Package Description: | 10 KIT in 1 BOX (51292-111-12) > 1 KIT in 1 KIT * 15.75 mg in 1 VIAL, SINGLE-DOSE (51292-121-01) * .6 mL in 1 SYRINGE (51292-131-01) |
| NDC Code | 51292-111-12 |
| Proprietary Name | IPRIVASK |
| Package Description | 10 KIT in 1 BOX (51292-111-12) > 1 KIT in 1 KIT * 15.75 mg in 1 VIAL, SINGLE-DOSE (51292-121-01) * .6 mL in 1 SYRINGE (51292-131-01) |
| Product NDC | 51292-111 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | DESIRUDIN |
| Dosage Form Name | KIT |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20100830 |
| Marketing Category Name | NDA |
| Labeler Name | CANYON PHARMACEUTICALS, INC |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |